2013Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Single-dose and multi-dose pharmacokinetics and bioavailability of ofloxacin sustained-release tablets in healthy volunteers

Zhong Guo-pin

Open publisher page 0 citations

Abstract

AIM:To study the single-dose and multi-dose pharmacokinetics and bioavailability of ofloxacin sustained-release tablets in healthy volunteers.METHODS:The plasma concentrations of ofloxacin were determined by a RPHPLC method.The reference or test preparation was given to healthy male volunteers according to an open randomized crossover study. The pharmacokinetic parameters and bioavailability of test preparation were compared with reference preparation.RESULTS:The main pharmacokinetic parameters of the test preparation and the reference preparation,the single-dose were as follows:Cmax were(5382± 1558)and(3419±1034)μg/L,Tmax were(1.7±0.6)and(4.2±1.8)h,t1/2 were(8.2±1.0)and(7.6± 1.8)h,MRT were(8.6±0.9)and(10.3±1.4) h;AUC0-t were(33764±5297)and(31280± 4412)μg·L-1·h,AUC0→∞ were(34643± 5356)and(32642±4257)μg·L-1·h.The relative bioavailability of reference to test preparation was(97.9±12.4)%.There were statistical-ly significant difference about Cmax,Tmax,MRT between the reference preparation and test preparation,but there were no statistically significant difference about t1/2,AUC0-t,AUC0→∞. The 90% confidence limit of AUC0-t and AUC0→∞ between the reference preparation and test preparation were 89.0%- 97.0% and 91.4%-97.8% respectively.The multi-dose were as follows:Cmax were(3732±1502)and(3564±982)μg/L,Cmin were(750±193),(438 ±89)μg/L,Tmax were(1.5±0.5)and(3.7± 1.7)h,AUCSS were(32689±4786)and(33591 ±7929)μg·L-1·h,Cav were(1362±199)and(1405±337)μg/L,DF were(216±76)and(222 ±34)%.The relative bioavailability of reference to test preparation was(102.9±22.5)%.There were no statistically significant difference about Cmax,Cav,AUCSS,DF between the reference preparation and test preparation.The 90%confidence limit of Cmax,AUCSS,Cav and DF were 80.8%-114.6%,89.3%-111.9%,89.5%-112.4% and 93.7%-122.4%.CONCLUSION: The results of statistics analysis showed that the test preparation exhibited sustained-release characteristics,and it was bioequivalent between the test preparation and the reference preparation.

About this research paper

What this paper is about

AIM:To study the single-dose and multi-dose pharmacokinetics and bioavailability of ofloxacin sustained-release tablets in healthy volunteers.METHODS:The plasma concentrations of ofloxacin were determined by a RPHPLC method.The reference or test preparation was given to healthy male volunteers according to an open randomized crossover study. The pharmacokinetic parameters and bioavailability of test preparation were compared with reference preparation.RESULTS:The main pharmacokinetic parameters of the test preparation and the reference preparation,the single-dose were as follows:Cmax were(5382± 1558)and(3419±1034)μg/L,Tmax were(1.7±0.6)and(4.2±1.8)h,t1/2 were(8.2±1.0)and(7.6± 1.8)h,MRT were(8.6±0.9)and(10.3±1.4) h;AUC0-t were(33764±5297)and(31280± 4412)μg·L-1·h,AUC0→∞ were(34643± 5356)and(32642±4257)μg·L-1·h.The relative bioavailability of reference to test preparation was(97.9±12.4)%.There were statistical-ly significant difference about Cmax,Tmax,MRT between the reference preparation and test preparation,but there were no statistically significant difference about t1/2,AUC0-t,AUC0→∞. The 90% confidence limit of AUC0-t and AUC0→∞ between the reference preparation and test preparation were 89.0%- 97.0% and 91.4%-97.8% respectively.The multi-dose were as follows:Cmax were(3732±1502)and(3564±982)μg/L,Cmin were(750±193),(438 ±89)μg/L,Tmax were(1.5±0.5)and(3.7± 1.7)h,AUCSS were(32689±4786)and(33591 ±7929)μg·L-1·h,Cav were(1362±199)and(1405±337)μg/L,DF were(216±76)and(222 ±34)%.The relative bioavailability of reference to test preparation was(102.9±22.5)%.There were no statistically significant difference about Cmax,Cav,AUCSS,DF between the reference preparation and test preparation.The 90%confidence limit of Cmax,AUCSS,Cav and DF were 80.8%-114.6%,89.3%-111.9%,89.5%-112.4% and 93.7%-122.4%.CONCLUSION: The results of statistics analysis showed that the test preparation exhibited sustained-release characteristics,and it was bioequivalent between the test preparation and the reference preparation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To study the single-dose and multi-dose pharmacokinetics and bioavailability of ofloxacin sustained-release tablets in healthy volunteers.METHODS:The plasma concentrations of ofloxacin were determined by a RPHPLC method.The reference or test preparation was given to healthy male volunteers according to an open randomized crossover study. The pharmacokinetic parameters and bioavailability of test preparation were compared with reference preparation.RESULTS:The main pharmacokinetic parameters of the test preparation and the reference preparation,the single-dose were as follows:Cmax were(5382± 1558)and(3419±1034)μg/L,Tmax were(1.7±0.6)and(4.2±1.8)h,t1/2 were(8.2±1.0)and(7.6± 1.8)h,MRT were(8.6±0.9)and(10.3±1.4) h;AUC0-t were(33764±5297)and(31280± 4412)μg·L-1·h,AUC0→∞ were(34643± 5356)and(32642±4257)μg·L-1·h.The relative bioavailability of reference to test preparation was(97.9±12.4)%.There were statistical-ly significant difference about Cmax,Tmax,MRT between the reference preparation and test preparation,but there were no statistically significant difference about t1/2,AUC0-t,AUC0→∞. The 90% confidence limit of AUC0-t and AUC0→∞ between the reference preparation and test preparation were 89.0%- 97.0% and 91.4%-97.8% respectively.The multi-dose were as follows:Cmax were(3732±1502)and(3564±982)μg/L,Cmin were(750±193),(438 ±89)μg/L,Tmax were(1.5±0.5)and(3.7± 1.7)h,AUCSS were(32689±4786)and(33591 ±7929)μg·L-1·h,Cav were(1362±199)and(1405±337)μg/L,DF were(216±76)and(222 ±34)%.The relative bioavailability of reference to test preparation was(102.9±22.5)%.There were no statistically significant difference about Cmax,Cav,AUCSS,DF between the reference preparation and test preparation.The 90%confidence limit of Cmax,AUCSS,Cav and DF were 80.8%-114.6%,89.3%-111.9%,89.5%-112.4% and 93.7%-122.4%.CONCLUSION: The results of statistics analysis showed that the test preparation exhibited sustained-release characteristics,and it was bioequivalent between the test preparation and the reference preparation.

Key concepts: Bioavailability, Cmax, Pharmacokinetics, Cmin, Pharmacology, Bioequivalence, Chemistry, Test preparation

Related papers

Back to paper searchBrowse research topicsOriginal source
Single-dose and multi-dose pharmacokinetics and bioavailability of ofloxacin sustained-release tablets in healthy volunteers — Research Paper | ScholarLens